|
|
||||||||


* Medical Research Service, Veterans Affairs Puget Sound Health Care System and Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98108;
Department of Pathology, Medical College of Georgia, Augusta, GA 30912; and
Department of Surgery, Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Bethesda, MD 20814
The Duffy Ag expressed on RBCs, capillaries, and postcapillary venular endothelial cells binds selective CXC and CC chemokines with high affinity. Cells transfected with the Duffy Ag internalize but do not degrade chemokine ligand. It has been proposed that Duffy Ag transports chemokines across the endothelium. We hypothesized that Duffy Ag participates in the movement of chemokines across the endothelium and, by doing so, modifies neutrophil transmigration. We found that the Duffy Ag transfected into human endothelial cells facilitates movement of the radiolabeled CXC chemokine, growth related oncogene-
/CXC chemokine ligand 1 (GRO-
/CXCL1), across an endothelial monolayer. In addition, neutrophil migration toward GRO-
/CXCL1 and IL-8 (IL-8/CXCL8) was enhanced across an endothelial monolayer expressing the Duffy Ag. Furthermore, GRO-
/CXCL1 stimulation of endothelial cells expressing the Duffy Ag did not affect gene expression by oligonucleotide microarray analysis. These in vitro observations are supported by the finding that IL-8/CXCL8-driven neutrophil recruitment into the lungs was markedly attenuated in transgenic mice lacking the Duffy Ag. We conclude that Duffy Ag has a role in enhancing leukocyte recruitment to sites of inflammation by facilitating movement of chemokines across the endothelium.
This article has been cited by other articles:
![]() |
V. Vielhauer, R. Allam, M. T. Lindenmeyer, C. D. Cohen, D. Draganovici, J. Mandelbaum, N. Eltrich, P. J. Nelson, H.-J. Anders, M. Pruenster, et al. Efficient Renal Recruitment of Macrophages and T Cells in Mice Lacking the Duffy Antigen/Receptor for Chemokines Am. J. Pathol., July 1, 2009; 175(1): 119 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Borroni, R. Bonecchi, A. Mantovani, and M. Locati Chemoattractant Receptors and Leukocyte Recruitment: More Than Cell Migration Sci. Signal., February 24, 2009; 2(59): pe10 - pe10. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Mangalmurti, Z. Xiong, M. Hulver, M. Ranganathan, X. H. Liu, T. Oriss, M. Fitzpatrick, M. Rubin, D. Triulzi, A. Choi, et al. Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation Blood, January 29, 2009; 113(5): 1158 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Zabel, S. Nakae, L. Zuniga, J.-Y. Kim, T. Ohyama, C. Alt, J. Pan, H. Suto, D. Soler, S. J. Allen, et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis J. Exp. Med., September 29, 2008; 205(10): 2207 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chakera, R. M. Seeber, A. E. John, K. A. Eidne, and D. R. Greaves The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization Mol. Pharmacol., May 1, 2008; 73(5): 1362 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Horton, Y. Yu, S. Zaja-Milatovic, R. M. Strieter, and A. Richmond Opposing Roles of Murine Duffy Antigen Receptor for Chemokine and Murine CXC Chemokine Receptor-2 Receptors in Murine Melanoma Tumor Growth Cancer Res., October 15, 2007; 67(20): 9791 - 9799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lee, M. M. Wurfel, G. Matute-Bello, C. W. Frevert, M. R. Rosengart, M. Ranganathan, V. W. Wong, T. Holden, S. Sutlief, A. Richmond, et al. The Duffy Antigen Modifies Systemic and Local Tissue Chemokine Responses following Lipopolysaccharide Stimulation J. Immunol., December 1, 2006; 177(11): 8086 - 8094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schiavo, D. Baatar, P. Olkhanud, F. E. Indig, N. Restifo, D. Taub, and A. Biragyn Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses Blood, June 15, 2006; 107(12): 4597 - 4605. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sfriso, F. Oliviero, F. Calabrese, M. Miorin, M. Facco, A. Contri, A. Cabrelle, I. Baesso, F. Cozzi, M. Andretta, et al. Epithelial CXCR3-B Regulates Chemokines Bioavailability in Normal, but Not in Sjogren's Syndrome, Salivary Glands J. Immunol., February 15, 2006; 176(4): 2581 - 2589. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, R. Schuster, K. F. Stringer, S. E. Waltz, and A. B. Lentsch The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth FASEB J, January 1, 2006; 20(1): 59 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Galliera, V. R. Jala, J. O. Trent, R. Bonecchi, P. Signorelli, R. J. Lefkowitz, A. Mantovani, M. Locati, and B. Haribabu {beta}-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6 J. Biol. Chem., June 11, 2004; 279(24): 25590 - 25597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weber, E. Blair, C. V. Simpson, M. O'Hara, P. E. Blackburn, A. Rot, G. J. Graham, and R. J.B. Nibbs The Chemokine Receptor D6 Constitutively Traffics to and from the Cell Surface to Internalize and Degrade Chemokines Mol. Biol. Cell, May 1, 2004; 15(5): 2492 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kashiwazaki, T. Tanaka, H. Kanda, Y. Ebisuno, D. Izawa, N. Fukuma, N. Akimitsu, K. Sekimizu, M. Monden, and M. Miyasaka A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions Int. Immunol., October 1, 2003; 15(10): 1219 - 1227. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |